John T. Delacourt

Deputy General Counsel, VP, Health, Regulatory & Commercial Operations at Biotechnology Innovation Organization (BIO)

Speaker

Agenda Sessions

• Navigating the Inflation Reduction Act, 340B Drug Program Litigation & Other Developments in Pricing

  Oct 14, 11:00am

  View Session

At this event